JHS Svendgaard Laboratories Limited
NSE: JHS BSE: JHS
Prev Close
10.98
Open Price
10.81
Volume
157,055
Today Low / High
10.69 / 11.19
52 WK Low / High
10.5 / 32.69
Range
10 - 11
Prev Close
10.94
Open Price
11.58
Volume
10,073
Today Low / High
10.68 / 11.58
52 WK Low / High
10.68 / 32.9
Range
10 - 12
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 10.91 (target range: 10 - 11), reflecting a change of -0.07 (-0.63752%). On the BSE, it is listed at 10.98 (target range: 10 - 12), showing a change of 0.04 (0.36563%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.
JHS Svendgaard Laboratories Limited Graph
JHS Svendgaard Laboratories Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for JHS Svendgaard Laboratories Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 10.91, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 10.98 | 11.09 | 9.98 - 12.20 |
| 11.20 | 8.96 - 13.44 | ||
| 11.31 | 7.92 - 14.70 | ||
| Bearish Scenario | 10.98 | 10.87 | 9.78 - 11.96 |
| 10.76 | 8.61 - 12.91 | ||
| 10.65 | 7.46 - 13.85 |
Overview of JHS Svendgaard Laboratories Limited
ISIN
INE544H01014
Industry
Household & Personal Products
Vol.Avg
117,437
Market Cap
933,939,640
Last Dividend
0
Official Website
IPO Date
2006-10-23
DCF Diff
26.15
DCF
-13
Financial Ratios Every Investor Needs
Stock Dividend of JHS
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2011-12-26 | December 26, 11 | 0.75 | 0.75 | 2011-12-27 | 2012-01-30 | 2011-11-29 |
| 2010-12-22 | December 22, 10 | 0.5 | 0.5 | 2010-12-23 | 2011-01-11 | 2010-05-30 |
| 2009-09-10 | September 10, 09 | 0.25 | 0.25 | 2009-09-12 | 2009-10-09 | 2009-07-01 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 92.00 Cr | 61.04 Cr | 30.96 Cr | 0.3365 | 0.00 Cr | 0.00 Cr | -11.96 Cr | -19.74 Cr | -2.37 | -3.99 Cr | -0.2146 |
| 2024-03-31 | 69.81 Cr | 49.45 Cr | 20.36 Cr | 0.2916 | 0.14 Cr | 1.74 Cr | -6.27 Cr | -4.06 Cr | -0.52 | 3.38 Cr | -0.0581 |
| 2023-03-31 | 84.08 Cr | 67.54 Cr | 16.55 Cr | 0.1968 | 0.07 Cr | 4.57 Cr | -14.60 Cr | -17.52 Cr | -2.23 | -16.38 Cr | -0.2083 |
| 2022-03-31 | 85.49 Cr | 65.32 Cr | 20.17 Cr | 0.2359 | 0.07 Cr | 1.69 Cr | -4.19 Cr | -4.05 Cr | -0.63 | 8.54 Cr | -0.0474 |
| 2021-03-31 | 100.07 Cr | 73.67 Cr | 26.40 Cr | 0.2638 | 0.00 Cr | 1.76 Cr | 3.67 Cr | 1.20 Cr | 0.20 | 9.46 Cr | 0.0120 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 6.75 Cr | 201.17 Cr | 28.44 Cr | 172.7272 Cr | 6.46 Cr | -0.29 Cr | 11.88 Cr | 87.04 Cr | 0.00 Cr | 0.00 Cr | 7.97 Cr | 24.7081 Cr |
| 2024-03-31 | 9.10 Cr | 197.05 Cr | 27.17 Cr | 169.8840 Cr | 5.13 Cr | -3.98 Cr | 12.65 Cr | 87.82 Cr | 0.00 Cr | 1.19 Cr | 3.97 Cr | 23.3371 Cr |
| 2023-03-31 | 37.25 Cr | 228.23 Cr | 54.39 Cr | 173.8406 Cr | 15.51 Cr | -21.74 Cr | 13.00 Cr | 72.83 Cr | 0.00 Cr | 1.30 Cr | 3.12 Cr | 36.7130 Cr |
| 2022-03-31 | 5.29 Cr | 221.99 Cr | 26.95 Cr | 185.9021 Cr | 6.18 Cr | 0.89 Cr | 12.10 Cr | 77.35 Cr | 0.00 Cr | 0.00 Cr | 0.89 Cr | 18.9091 Cr |
| 2021-03-31 | 20.79 Cr | 227.96 Cr | 30.00 Cr | 188.6955 Cr | 7.01 Cr | -13.78 Cr | 11.64 Cr | 70.99 Cr | 1.51 Cr | 0.00 Cr | 0.00 Cr | 23.1303 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -5.1779 Cr | -22.0182 Cr | 23.0712 Cr | -15.7109 Cr | -2.3592 Cr | 6.7455 Cr | -10.5330 Cr | -12.5076 Cr | 1.5846 Cr | 0.0000 Cr | 0.7743 Cr |
| 2024-03-31 | -8.5842 Cr | -21.7336 Cr | 2.1738 Cr | -40.1168 Cr | -28.1440 Cr | 9.1047 Cr | -31.5326 Cr | -15.4638 Cr | 3.1793 Cr | 0.0000 Cr | 0.3485 Cr |
| 2023-03-31 | 23.2862 Cr | 9.6770 Cr | -0.8999 Cr | 8.9426 Cr | 32.3263 Cr | 37.5117 Cr | -14.3436 Cr | -22.9511 Cr | -0.2068 Cr | 0.0000 Cr | -1.2190 Cr |
| 2022-03-31 | -9.1361 Cr | -4.6966 Cr | -1.6716 Cr | -15.8748 Cr | -15.5043 Cr | 5.2881 Cr | -6.7387 Cr | 0.1030 Cr | -0.6913 Cr | 0.0000 Cr | -0.7207 Cr |
| 2021-03-31 | 12.0290 Cr | -2.2252 Cr | 10.3088 Cr | 3.6963 Cr | 20.1126 Cr | 20.7924 Cr | -8.3327 Cr | 0.9678 Cr | 0.1287 Cr | 0.0000 Cr | -5.8719 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 25.17 Cr | 19.43 Cr | 5.74 Cr | 0.2281 | -7.40 Cr | -6.96 Cr | -0.84 | -6.81 Cr | -0.2765 |
| 2024-12-31 | 22.66 Cr | 14.14 Cr | 8.52 Cr | 0.3760 | -1.73 Cr | -1.84 Cr | -0.21 | 0.52 Cr | -0.0811 |
| 2024-09-30 | 19.68 Cr | 13.13 Cr | 6.55 Cr | 0.3327 | -2.83 Cr | -10.32 Cr | -1.24 | 0.01 Cr | -0.5243 |
| 2024-06-30 | 24.48 Cr | 18.83 Cr | 5.66 Cr | 0.2311 | 0.00 Cr | -0.63 Cr | -0.08 | 2.29 Cr | -0.0257 |
| 2024-03-31 | 21.66 Cr | 19.04 Cr | 2.63 Cr | 0.1212 | -1.07 Cr | -0.75 Cr | -0.10 | 2.21 Cr | -0.0347 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 6.75 Cr | 13.27 Cr | 20.02 Cr | 13.06 Cr | 11.88 Cr | 53.83 Cr | 87.04 Cr | 201.17 Cr | 28.44 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 5.82 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -181.46 Cr |
| 2024-09-30 | 1.33 Cr | 5.32 Cr | 6.65 Cr | 14.52 Cr | 13.36 Cr | 40.67 Cr | 88.68 Cr | 207.58 Cr | 26.12 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 10.36 Cr | 0.00 Cr | 0.00 Cr | 10.36 Cr | 0.00 Cr | 0.00 Cr | -169.88 Cr |
| 2024-03-31 | 4.70 Cr | 0.35 Cr | 10.36 Cr | 12.88 Cr | 12.65 Cr | 43.66 Cr | 87.82 Cr | 197.05 Cr | 27.17 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | -1.84 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | -10.32 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | -0.63 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | -12.16 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | 0.01 Cr | 3.25 Cr | 0.00 Cr | 0.00 Cr | 3.25 Cr | 9.22 Cr | 5.97 Cr | 0.00 Cr | 3.25 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Household & Personal Products
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Hindustan Unilever Limited | HINDUNILVR | ₹2,629.90 | ₹6,179,186,741,000.00 | ₹1,223,310.00 |
| Godrej Consumer Products Limited | GODREJCP | ₹1,257.20 | ₹1,286,203,604,000.00 | ₹1,481,293.00 |
| Marico Limited | MARICO | ₹730.70 | ₹948,368,223,000.00 | ₹1,579,149.00 |
| Dabur India Limited | DABUR | ₹515.95 | ₹915,135,355,500.00 | ₹1,595,875.00 |
| Colgate-Palmolive (India) Limited | COLPAL | ₹2,299.30 | ₹625,377,409,800.00 | ₹621,152.00 |
| Procter & Gamble Hygiene and Health Care Limited | PGHH | ₹13,307.00 | ₹431,954,534,900.00 | ₹9,246.00 |
| Gillette India Limited | GILLETTE | ₹10,395.00 | ₹338,723,154,000.00 | ₹22,062.00 |
| Emami Limited | EMAMILTD | ₹611.95 | ₹268,695,006,000.00 | ₹428,658.00 |
| Jyothy Labs Limited | JYOTHYLAB | ₹340.65 | ₹125,091,449,100.00 | ₹158,609.00 |
| Honasa Consumer Limited | HONASA | ₹300.05 | ₹97,571,345,181.00 | ₹1,240,624.00 |
| Cupid Limited | CUPID | ₹171.94 | ₹46,160,215,980.00 | ₹4,174,952.00 |
| Bajaj Consumer Care Limited | BAJAJCON | ₹226.51 | ₹31,159,621,640.00 | ₹351,411.00 |
| S H Kelkar and Company Limited | SHK | ₹225.00 | ₹31,144,725,000.00 | ₹156,232.00 |
Key Executives
Gender: male
Year Born: 1985
Gender: male
Year Born:
Gender: female
Year Born:
Gender: male
Year Born: 1978
Gender: male
Year Born:
Gender: male
Year Born: 1972
FAQs about JHS Svendgaard Laboratories Limited
The CEO is Paramvir Singh Pabla.
The current price is ₹10.91.
The range is ₹10.5-32.69.
The market capitalization is ₹93.39 crores.
The P/E ratio is -4.60.
The company operates in the Consumer Defensive sector.
Overview of JHS Svendgaard Laboratories Limited (ISIN: INE544H01014) is a leading Household & Personal Products in India. With a market capitalization of ₹93.39 crores and an average daily volume of 117,437 shares, it operates in the Household & Personal Products. The company last declared a dividend of ₹0.